BioNTech SE (BNTX) Consolidated Net Income (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Consolidated Net Income data on file, last reported at -$174.4 million in Q4 2025.

• In Q4 2025, Consolidated Net Income fell 147.59% year-over-year to -$174.4 million; the TTM figure through Dec 2025 stood at -$1.1 billion (down 52.42% YoY), while the FY2025 annual figure was -$1.3 billion, down 80.55% from the prior year.
• Consolidated Net Income slipped to -$174.4 million in Q4 2025, from -$33.6 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $7.2 billion in Q3 2021 and bottomed at -$865.6 million in Q2 2024.
• A 5-year average of $1.5 billion and a median of $452.7 million in 2024 frame the typical range for Consolidated Net Income.
• Annual changes were most pronounced in 2021 — Consolidated Net Income soared 1637460123.4% — and 2024, when it tumbled 163.51%.
• Year by year, Consolidated Net Income stood at $7.2 billion in 2021, then slumped by 67.54% to $2.3 billion in 2022, then sank by 59.81% to $934.5 million in 2023, then tumbled by 60.79% to $366.4 million in 2024, then slumped by 147.59% to -$174.4 million in 2025.
• The last three Consolidated Net Income figures came in at -$174.4 million (Q4 2025), -$33.6 million (Q3 2025), and -$437.6 million (Q2 2025), per Business Quant data.

Peer Comparison